ALGS logo

Aligos Therapeutics (ALGS) Shareholders Equity

Annual Shareholders Equity

-$28.97 M
-$121.05 M-131.47%

December 31, 2024


Summary


Performance

ALGS Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherALGSbalance sheetmetrics:

Quarterly Shareholders Equity

-$28.97 M
-$79.07 M-157.83%

December 31, 2024


Summary


Performance

ALGS Quarterly Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherALGSbalance sheetmetrics:

Shareholders Equity Formula

Shareholders Equity = Total Assets − Total Liabilities

ALGS Shareholders Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-131.5%-157.8%
3 y3 years-115.7%-134.2%
5 y5 years+55.4%-134.2%

ALGS Shareholders Equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-115.7%at low-115.7%at low
5 y5-year-113.2%+55.4%-113.2%+78.8%
alltimeall time-113.2%+55.4%-113.2%+78.8%

Aligos Therapeutics Shareholders Equity History

DateAnnualQuarterly
Dec 2024
-$28.97 M(-131.5%)
-$28.97 M(-157.8%)
Sep 2024
-
$50.10 M(-25.5%)
Jun 2024
-
$67.23 M(+12.4%)
Mar 2024
-
$59.80 M(-35.1%)
Dec 2023
$92.08 M(-11.4%)
$92.08 M(+68.0%)
Sep 2023
-
$54.82 M(-21.3%)
Jun 2023
-
$69.64 M(-17.8%)
Mar 2023
-
$84.75 M(-18.4%)
Dec 2022
$103.90 M
$103.90 M(-14.8%)
Sep 2022
-
$122.01 M(-10.9%)
DateAnnualQuarterly
Jun 2022
-
$136.98 M(-10.4%)
Mar 2022
-
$152.89 M(-17.2%)
Dec 2021
$184.73 M(-16.0%)
$184.73 M(-14.9%)
Sep 2021
-
$217.01 M(+28.5%)
Jun 2021
-
$168.88 M(-13.5%)
Mar 2021
-
$195.22 M(-11.3%)
Dec 2020
$220.04 M(-439.1%)
$220.04 M(-261.0%)
Sep 2020
-
-$136.67 M(-212.1%)
Jun 2020
-
$121.96 M(-287.9%)
Dec 2019
-$64.89 M(+372.0%)
-$64.89 M
Dec 2018
-$13.75 M
-

FAQ

  • What is Aligos Therapeutics annual stockholders equity?
  • What is the all time high annual shareholders equity for Aligos Therapeutics?
  • What is Aligos Therapeutics annual shareholders equity year-on-year change?
  • What is Aligos Therapeutics quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Aligos Therapeutics?
  • What is Aligos Therapeutics quarterly shareholders equity year-on-year change?

What is Aligos Therapeutics annual stockholders equity?

The current annual shareholders equity of ALGS is -$28.97 M

What is the all time high annual shareholders equity for Aligos Therapeutics?

Aligos Therapeutics all-time high annual stockholders equity is $220.04 M

What is Aligos Therapeutics annual shareholders equity year-on-year change?

Over the past year, ALGS annual stockholders equity has changed by -$121.05 M (-131.47%)

What is Aligos Therapeutics quarterly stockholders equity?

The current quarterly shareholders equity of ALGS is -$28.97 M

What is the all time high quarterly shareholders equity for Aligos Therapeutics?

Aligos Therapeutics all-time high quarterly stockholders equity is $220.04 M

What is Aligos Therapeutics quarterly shareholders equity year-on-year change?

Over the past year, ALGS quarterly stockholders equity has changed by -$79.07 M (-157.83%)